Research Tracker›Biomarker Atlas›Type 2 Diabetes›HbA1c

HbA1c in Type 2 Diabetes

HbA1c is a metabolic marker reported as elevated in Type 2 Diabetes when patients are compared with the reference group of the cited comparison (T2DM vs healthy controls). The source does not tie this marker to a specific symptom cluster, so it is best read as a biological signal rather than a symptom predictor. The finding is drawn from Arif et al. 2024; it describes group-level differences, not a threshold that classifies an individual.

↑ ElevatedMetabolic

Summary

Direction in Type 2 Diabetes↑ Elevated — higher than in the comparison group
CategoryMetabolic
Compared againstT2DM vs healthy controls
SourceArif et al. 2024 — doi:10.6026/973206300200202
Condition atlasType 2 Diabetes Biomarker Atlas

Other conditions where HbA1c is reported

See the cross-condition hub: HbA1c across conditions.

Related Metabolic markers in Type 2 Diabetes

Full list: Type 2 Diabetes Biomarker Atlas.

Frequently asked questions

Is HbA1c high or low in Type 2 Diabetes?

Elevated. Studies summarised in the OSMF atlas report higher HbA1c in Type 2 Diabetes than in the reference group of the cited comparison (T2DM vs healthy controls). Source: Arif et al. 2024.

Which test measures HbA1c?

The atlas record does not list a standardised clinical test code (LOINC) for HbA1c, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal HbA1c result diagnostic of Type 2 Diabetes?

No. No single biomarker is diagnostic of Type 2 Diabetes. HbA1c findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is HbA1c specific to Type 2 Diabetes?

No. The same marker is also reported in Type 1 Diabetes in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). HbA1c in Type 2 Diabetes: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/type-2-diabetes/hba1c.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-07-02 · Page generated from type-2-diabetes.json · Browse: Type 2 Diabetes atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.